Compendia Bioscience, founded in 2006 by a University of Michigan medical school professor and one of his grad students, was acquired Monday by Life Technologies Corp.
Terms of the deal were not disclosed.
The private Ann Arbor-based company with 34 employees markets an oncology database that pharmaceutical companies use to develop new drugs and identify patients who might benefit from the therapies.
The database, Oncomine, was developed by U-M Medical School professor Arul Chinnaiyan, a pioneer in the field of cancer research, and his student Daniel Rhodes, Compendia's chief executive officer. The database has become a standard in oncology research and drug development, serving the top cancer drug companies in the world.
To read the rest of this story, please follow this link to the full text on the U-M News Service website: http://www.ns.umich.edu/new/releases/20842-u-m-startup-compendia-bioscience-acquired-by-life-technologies